SCHEMBL15219626

SCHEMBL15219626

CC(=O)[C@@H](NC(=O)Cc1cccnc1)C(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C9 P11712 1/20 0.58
NAPRT Q6XQN6 1/20 0.49
EPHX2 P34913 1/20 0.48
ECE1 P42892 1/20 0.46
ERCC1 P07992 1/20 0.45
ERCC4 Q92889 1/20 0.45
GAA P10253 1/20 0.44
MAPK8 P45983 1/20 0.43
PSMB8 P28062 1/20 0.43
PSMB5 P28074 1/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
FFAR2 O15552 1/20 0.43
GLS O94925 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12330584 1.00 CYP1A2 (0.58) CYP1A2CYP3A4CYP2C9NAPRTEPHX2
SCHEMBL12401390 0.88 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C9NAPRTEPHX2
SCHEMBL12401076 0.88 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C9NAPRTEPHX2
SCHEMBL15219639 0.87 CYP1A2 (0.50) CYP1A2CYP3A4CYP2C9ALDH1A1MAPT
SCHEMBL12467243 0.87 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C9NAPRTEPHX2
SCHEMBL12467076 0.87 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C9NAPRTEPHX2
SCHEMBL14943683 0.83 MEN1 (0.55) CYP1A2CYP3A4CYP2C9PSMB8PSMB5
SCHEMBL16330242 0.82 ALDH1A1 (0.55) LMNAALDH1A1MAPTHTTPKM
SCHEMBL14943743 0.81 CYP3A4 (0.54) CYP3A4LMNAALDH1A1MAPTHTT
SCHEMBL24011470 0.80 CYP1A2 (0.64) CYP1A2CYP3A4CYP2C9NAPRTEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
US-7964624-B1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-21 US disclosed